[Federal Register Volume 62, Number 5 (Wednesday, January 8, 1997)]
[Notices]
[Page 1120]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-461]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Vaccine Advisory Committee (NVAC), Subcommittee on
Vaccine Safety, Subcommittee on Immunization Coverage, Subcommittee on
Future Vaccines, and the Advisory Commission on Childhood Vaccines
(ACCV), Subcommittee on Vaccine Safety: Meetings
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Federal advisory committee
meetings.
Name: National Vaccine Advisory Committee (NVAC).
Times and Dates: 9 a.m.-2 p.m., January 13, 1997; 8:30 a.m.-12:45
p.m., January 14, 1997.
Place: Hubert H. Humphrey Building, Room 503A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Notice: In the interest of security, the Department has instituted
stringent procedures for entrance to the Hubert H. Humphrey Building by
non-government employees. Thus, persons without a government
identification card should plan to arrive at the building each day
either between 8 and 8:30 a.m. or 12:30 and 1 p.m. so they can be
escorted to the meeting. Entrance to the meeting at other times during
the day cannot be assured.
Purpose: The Committee shall advise and make recommendations to the
Director of the National Vaccine Program on matters related to the
Program responsibilities.
Matters To Be Discussed: Agenda items include: A discussion of the
National Vaccine Program Office highlights; managed care and Medicaid:
ensuring optimal childhood immunization; managed care and immunization:
American Association of Health Plan vaccine promotion activities;
implementation of new recommendations for polio immunization; Public
Broadcasting System's Nova Tape: Deadly Deception; report of meeting on
case studies in vaccine research and developments from the Cold Spring
Harbor meeting; adult immunization, Department of Health and Human
Services Work Group; role of non-traditional providers for adult
immunization; pandemic influenza preparedness plan; update on personal
responsibility concept paper and leverage paper from the Subcommittee
on Immunization Coverage; report from NVAC's Subcommittee on Vaccine
Safety; status of the National Vaccine Plan.
Agenda items are subject to change as priorities dictate.
Name: NVAC Subcommittee on Vaccine Safety and the ACCV Subcommittee
on Vaccine Safety.
Time and Date: 2 p.m.-5 p.m., January 13, 1997.
Place: Hubert H. Humphrey Building, Room 425A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This joint NVAC/ACCV subcommittee will review issues
relevant to vaccine safety and adverse reactions to vaccines.
Matter to be Dicussed: The Subcommittee will discuss an update on
the recommendations of the Task Force on Safer Childhood Vaccines;
update on HHS/CDC response to funding on active surveillance; update on
vaccine risk communication; and clarification of mouse toxicity test.
Name: NVAC Subcommittee on Immunization Coverage.
Time and Date: 2 p.m.-5 p.m., January 13, 1997.
Place: Hubert H. Humphrey Building, Room 423A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will identify and propose solutions that
provide a multifaceted and holistic approach to reducing barriers that
result in low immunization coverage for children.
Matters to be Discussed: The Subcommittee will discuss the forum on
assessment and related immunization issues; the outline for the
Subcommittee's report; and the assessment of immunization coverage.
Name: NVAC Subcommittee on Future Vaccines.
Time and Date: 2 p.m.-5 p.m., January 13, 1997.
Place: Hubert H. Humphrey Building, Room 405A, 200 Independence
Avenue, SW, Washington, DC 20201.
Status: Open to the public, limited only by the space available.
Purpose: This subcommittee will develop policy options and guide
the National Vaccine Program activities which will lead to accelerated
development, licensure, and best use of new vaccines in the simplest
possible immunization schedules.
Matters to be Discussed: The Subcommittee will discuss an update on
vaccine procurement strategies and case studies in vaccine development.
This notice is being published less than 15 days prior to the meeting
due to programmatic issues that had to be resolved.
CONTACT PERSON FOR MORE INFORMATION: Felecia D. Pearson, Committee
Management Specialist, National Vaccine Program Office, CDC, 1600
Clifton Road, NE, M/S D50, Atlanta, Georgia 30333, telephone 404/639-
7250.
Dated: January 3, 1997.
Joseph E. Salter,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention (CDC).
[FR Doc. 97-461 Filed 1-6-97; 11:53 am]
BILLING CODE 4163-18-P
